Lonza Group stock holds near 52-week high on solid first-half momentum

Published on 09/01/2026 at 18:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza Group stock is trading close to its 52-week high on the SIX Swiss Exchange, with investors focusing on the company’s first-half 2026 growth and its role as a preferred life sciences tools name alongside European peers.

Flatlay von Laborutensilien auf weißem Tisch: Pipetten, Petrischalen und blaue Schutzhandschuhe — Lonza CH0013841017 Flatlay Labor Pipetten Petrischalen blaue Schutzhandschuhe auf weissem Tisch anonym, Illustration mit AI erstellt.

Lonza Group (ISIN CH0013841017) stock is trading close to its recent 52-week high, with recent data from the SIX Swiss Exchange showing the shares around the mid-CHF 570 range as of early trading on September 1, 2026.

Stock stays supported near late-August highs

According to market data reported by finanzen.ch on September 1, 2026, Lonza Group shares traded at 578.00 CHF at 9:28 a.m. local time, up 0.2 percent from the opening price of 576.00 CHF on the SIX Swiss Exchange.

The same overview notes that Lonza reached a 52-week high of 597.80 CHF on August 25, 2026, meaning the current level is only about 3.3 percent below that recent peak, keeping Lonza among the stronger names in the Swiss Market Index environment.

First half 2026 performance anchors sentiment

Investor interest in Lonza Group has been underpinned by its first-half 2026 performance, with market commentary highlighting continued growth in its contract development and manufacturing services for the pharmaceutical and biotech industry.

Recent corporate coverage compiled by ad-hoc-news.de on September 1, 2026 points to robust first-half 2026 revenue growth and ongoing margin discipline at Lonza Group, reinforcing the view that the company’s latest half-year figures form the fundamental backdrop for the current share price zone near CHF 580.

Go deeper

More on Lonza Group stock and figures

Further details on Lonza Group’s latest share-price moves and reported numbers are available via the AD HOC NEWS topic overview and the company’s investor relations page.

Lonza Group stock on AD HOC NEWS Investor Relations

Representative product: contract manufacturing services

One representative pillar of Lonza Group’s business is its contract development and manufacturing organization services, which provide pharmaceutical and biotech customers with scalable production capacity for active ingredients, biologics and advanced therapies.

Share price level as of latest trading

As of the close on August 30, 2026, Lonza Group shares stood at 583.80 CHF on the SIX Swiss Exchange, with subsequent trading around 578.00 CHF on September 1, 2026 keeping the stock within a narrow corridor just below the 52-week high zone.